What’s going on here?
Thyssenkrupp nucera’s green hydrogen orders sank this year, with just €26 million in new deals booked—down sharply from €356 million last year—and the news is sending ripples through renewables.
What does this mean?
The company’s latest results signal a loss of momentum for green hydrogen, as projects are taking longer to materialize and order books are looking thin. Delays in engineering and project launches mean fresh revenue could be slow to arrive, prompting analysts at mwb Research to cut their price target from €12 to €10, and trim sales expectations for the next couple of years. Thyssenkrupp nucera’s 2026 guidance of €500 million to €600 million is a reality check, with this year’s order intake marking the weakest patch in recent memory. Still, experts highlight that the company’s fundamentals and its position in hydrogen remain steady, thanks in part to a strong balance sheet and reliable income from its industrial division.
Why should I care?
For markets: Hydrogen’s promise faces a patience test.
Fewer green hydrogen orders have clouded the outlook for Thyssenkrupp nucera, leading investors to brace for a longer timeline before major projects boost financial results. On the bright side, steady earnings from the chlorine-alkali business and robust cash reserves help cushion short-term bumps. The stock’s next moves will likely hinge on whether new contracts materialize and broader hydrogen momentum picks up speed.
The bigger picture: Clean energy’s road to maturity is bumpy.
Green hydrogen is seen as crucial for decarbonizing heavy industries, but scaling up comes with headaches—think policy uncertainty, slow-moving project pipelines, and lengthy engineering cycles. Thyssenkrupp nucera’s slowdown is a reminder that building a future-proof energy sector is anything but straightforward, and the sector’s roadblocks could reshape where investors and governments direct their money in the years ahead.
